This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovations of Petar Jelinic in Ovarian Cancer Research
Introduction
Petar Jelinic is a notable inventor based in New York, NY (US), recognized for his contributions to the field of cancer research. He has developed innovative methods and compositions aimed at diagnosing and treating ovarian cancers, particularly those associated with reduced SMARCA4 gene expression.
Latest Patents
Jelinic holds a patent for "Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function." This patent addresses the identification and treatment of small cell ovarian cancers, specifically small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). The invention focuses on the sensitivity of these cancers to compounds that can restore SMARCA4 gene expression and/or protein function, providing a potential therapeutic avenue for affected patients. He has 1 patent to his name.
Career Highlights
Petar Jelinic is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer treatment and research. His work at this prestigious center has allowed him to contribute significantly to advancements in oncology.
Collaborations
Throughout his career, Jelinic has collaborated with esteemed colleagues, including Michael Berger and Robert Soslow. These partnerships have further enriched his research and innovation in the field of cancer treatment.
Conclusion
Petar Jelinic's work exemplifies the critical role of innovation in the fight against ovarian cancer. His patented methods and compositions offer hope for improved diagnosis and treatment options for patients suffering from this challenging disease.